Medical news and careers, clearly connected
CareZelo
English
Menu

公共卫生动态

公共卫生加拿大

Baxter to discontinue 200 mg cyclophosphamide intravenous solution by year end 2026

Baxter Corporation reports its Procytox (cyclophosphamide) 200 mg powder for intravenous solution (DIN 02241797) will be discontinued on Dec 31, 2026, for business reasons. The discontinuation decision will not be reversed.

Cyclophosphamide is a standard chemotherapy drug — cancer care teams should plan the switch to another strength or product before Dec 31.

Discontinuation date: 2026年12月31日 所有截止日期

询问关于此简报的内容

回答由AI根据此简报生成，可能存在错误。请在采取行动前核实原始来源。

无需账户每天可免费提问2次。会员可随时免费提问，次数不限。

非医疗、法律或移民建议。问题将匿名保存以改进我们的简报。

阅读原文

官方来源: Baxter to discontinue 200 mg cyclophosphamide intravenous solution by year end 2026 （在新标签页中打开） — Health Product Shortages Canada

报告问题

20 天后截止公共卫生加拿大

Accel Pharma reports upcoming two-week shortage of ondansetron 8 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 8 mg (ACCEL-ONDANSETRON ODT, DIN 02535327) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

官方来源: Health Product Shortages Canada （在新标签页中打开）

20 天后截止公共卫生加拿大

Accel Pharma reports upcoming two-week shortage of ondansetron 4 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 4 mg (ACCEL-ONDANSETRON ODT, DIN 02535319) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

官方来源: Health Product Shortages Canada （在新标签页中打开）

39 天后截止公共卫生加拿大

Sandoz rabeprazole 20 mg supply disruption expected until early December

Sandoz Canada reports its rabeprazole sodium 20 mg enteric-coated tablet (DIN 02314185) faces an anticipated shortage from Oct 26 to Dec 4, 2026, after a disruption in the manufacture of the drug.

Rabeprazole is a commonly prescribed stomach-acid drug — prescribers and pharmacies should plan alternatives while the shortage is expected.

官方来源: Health Product Shortages Canada （在新标签页中打开）

18 天后截止公共卫生加拿大

Sandoz dexamethasone injection supply faces temporary shortage through mid-November

Sandoz Canada reports its dexamethasone sodium phosphate injection 10 mg/mL (DIN 00874582), for intravenous, intramuscular or intrasynovial use, faces an anticipated shortage from Oct 26 to Nov 13, 2026, driven by increased demand.

Dexamethasone injection is a staple steroid in hospitals and clinics — care teams should check stock before the anticipated shortage bites.

官方来源: Health Product Shortages Canada （在新标签页中打开）